| Literature DB >> 31396511 |
Tamás Maruzs1, Zsófia Simon-Vecsei2, Viktória Kiss1, Tamás Csizmadia2, Gábor Juhász1,2.
Abstract
Autophagy ensures the lysosome-mediated breakdown and recycling of self-material, as it not only degrades obsolete or damaged intracellular constituents but also provides building blocks for biosynthetic and energy producing reactions. Studies in animal models including Drosophila revealed that autophagy defects lead to the rapid decline of neuromuscular function, neurodegeneration, sensitivity to stress (such as starvation or oxidative damage), and stem cell loss. Of note, recently identified human Atg gene mutations cause similar symptoms including ataxia and mental retardation. Physiologically, autophagic degradation (flux) is known to decrease during aging, and this defect likely contributes to the development of such age-associated diseases. Many manipulations that extend lifespan (including dietary restriction, reduced TOR kinase signaling, exercise or treatment with various anti-aging substances) require autophagy for their beneficial effect on longevity, pointing to the key role of this housekeeping process. Importantly, genetic (e.g., Atg8a overexpression in either neurons or muscle) or pharmacological (e.g., feeding rapamycin or spermidine to animals) promotion of autophagy has been successfully used to extend lifespan in Drosophila, suggesting that this intracellular degradation pathway can rejuvenate cells and organisms. In this review, we highlight key discoveries and recent progress in understanding the relationship of autophagy and aging in Drosophila.Entities:
Keywords: Drosophila; aging; autophagy; dietary restriction (DR); spermidine
Year: 2019 PMID: 31396511 PMCID: PMC6667644 DOI: 10.3389/fcell.2019.00140
Source DB: PubMed Journal: Front Cell Dev Biol ISSN: 2296-634X
Drosophila autophagy-related genes and their functional analyses.
| Atg proteins in | Function | Loss of function phenotype | Gain of function phenotype | References |
|---|---|---|---|---|
| Atg1 | Serine/threonine kinase | Short lived, oxidative stress response defects, reduced dendritic growth, autophagy defect | Extended lifespan, improved intestinal barrier, reduced cell size, induced autophagy, induction of apoptosis, and organismal death upon strong overexpression | |
| Atg2 | Lipid transporter for autophagosome biogenesis | Short lived, decreased cell death, reduced dendritic growth, autophagy defect | – | |
| Atg3 (aka. Aut1) | E2-like enzyme, Atg8 ligase activity | Short lived, autophagy defect | – | |
| Atg4a | Cysteine-type endopeptidase | Accumulation of p62 positive aggregates, autophagy defect | – | |
| Atg4b | Cysteine-type endopeptidase | – | – | – |
| Atg5 | Atg8 ligase activity | Memory defect, autophagy defect, ataxia, reduced dendritic growth, impaired immune function | – | |
| Atg6 | Autophagosome assembly, late endosome-lysosome maturation | Autophagy defect, melanotic mass formation | – | |
| Atg7 | E1-type ligase, Atg8 and Atg12 activator enzyme | Short lived, memory defect, impaired immune function, autophagy defect | Extended lifespan | |
| Atg8a | Ubiquitin like protein, autophagosome assembly | Reduced dendritic growth, autophagy defect | Extended lifespan | |
| Atg8b | Ubiquitin like protein | – | – | |
| Atg9 | Organization of PAS, response to oxidative stress, JNK activation | Thicker and shorter midgut, memory defect, autophagy defect, short lived | Induced JNK activation | |
| Atg10 | E2-like enzyme, Atg12 transferase activity | – | – | – |
| Atg12 | Ubiquitin like protein, Atg8 ligase activity | Reduced immune function, autophagy defect | – | |
| Atg13 | Atg1 regulator activity | Short lived, autophagy defect | – | |
| Atg14 | Autophagosome assembly | Autophagy defect, decreased stem cell number in the gut | – | |
| Atg16 | Atg8 ligase activity | Defective immune responses, inflammation, thicker and shorter midgut, short lived, autophagy defect | – | |
| Atg17 (aka. FIP200) | Atg1 regulator activity | Short lived, autophagy defect | Enhanced autophagy |
FIGURE 1Anti-aging pathways in different tissues of Drosophila. The main pathways and proteins that counteract with aging in fat tissue, brain, intestine and skeletal muscle of Drosophila. Green: mechanisms and proteins that have anti-aging effects when they are activated or their levels are elevated. Red: mechanisms and proteins that have anti-aging effects when they are inhibited or their levels are decreased. Blue and magenta arrows represent activation and inhibition, respectively. DR, dietary restriction; Tor, Target of Rapamycin pathway; Foxo, forkhead box O transcription factor pathway; DILP, Drosophila Insulin-Like Peptide; AMPK, AMP-activated kinase. Please see text for further details.